Effect of low‐dose theophylline on airway inflammation in COPD

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Respirology (Carlton South. Print)

• Publication date

  2004-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1440-1843.2004.00573.xPMID 15182277
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution

  2023cited by this paper
• The extracellular release of granulocyte collagenase and elastase during phagocytosis and inflammatory processes.

  2009cited by this paper
• A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression

  2002cited by this paper
• Effect of theophylline on induced sputum inflammatory indices and neutrophil chemotaxis in chronic obstructive pulmonary disease.

  2002cited by this paper
• Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema

  2002cited by this paper
• Future Advances in COPD Therapy

  2001cited by this paper
• Low-dose theophylline reduces eosinophilic inflammation but not exhaled nitric oxide in mild asthma.

  2001cited by this paper
• Effect of a 4‐week treatment with theophylline on sputum eosinophilia and sputum eosinophil chemotactic activity in steroid‐naive asthmatics

  2000cited by this paper
• Safety of sputum induction in chronic obstructive pulmonary disease.

  2000cited by this paper
• Effects of theophylline on human eosinophil functions: comparative study with neutrophil functions

  2000cited by this paper
• Theophylline induces neutrophil apoptosis through adenosine A2A receptor antagonism

  2000cited by this paper
• Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease.

  1999cited by this paper
• Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema.

  1999cited by this paper
• Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease

  1998cited by this paper
• Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group.

  1997cited by this paper
• Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects.

  1997cited by this paper
• Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.

  1996cited by this paper
• Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD.

  1996cited by this paper
• Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils.

  1996cited by this paper
• Excessive neutrophil elastase in bronchoalveolar lavage fluid in subclinical emphysema.

  1995cited by this paper
• Theophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxants.

  1995cited by this paper
• Anti-inflammatory effects of low-dose oral theophylline in atopic asthma.

  1994cited by this paper
• The role of proteinases in the pathogenesis of chronic bronchitis.

  1994cited by this paper
• New perspectives on basic mechanisms in lung disease. 6. Proteinase imbalance: its role in lung disease.

  1993cited by this paper
• New perspectives on basic mechanisms in lung disease

  1992cited by this paper
• Aminophylline improves diaphragmatic contractility.

  1981cited by this paper
• Dosage of theophylline in bronchial asthma.

  1975cited by this paper
• EXPERIMENTAL EMPHYSEMA: ITS PRODUCTION WITH PAPAIN IN NORMAL AND SILICOTIC RATS.

  1965cited by this paper
• The Electrophoretic α;1-Globulin Pattern of Serum in α;1-Antitrypsin Deficiency

  1963cited by this paper

• Myeloperoxidase as a Biomarker in COPD.

  2025cites this paper
• Development and Optimization of RofA-PAMAM Dendrimer Complex Materials for Sustained Drug Delivery

  2022cites this paper
• Post-tuberculous lung disease: should we be using Theophylline?

  2021cites this paper
• Theophylline Derivatives' In-vivo Analgesic and Anti-Inflammatory Activities

  2021cites this paper
• The effect of doxofylline in asthma and COPD.

  2020cites this paper
• Chronic Obstructive Pulmonary Disease

  2020cites this paper
• Pharmacology and Therapeutics of Bronchodilators Revisited

  2019cites this paper
• Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease

  2019cites this paper
• Nicorandil and theophylline can protect experimental rats against complete Freund's adjuvant‐induced rheumatoid arthritis through modulation of JAK/STAT/RANKL signaling pathway

  2018cites this paper
• Pharmacokinetics, Pharmacodynamics, and Toxicities: What Should We Know About Genetic Factors that Affect the Pharmacotherapy of Pulmonary Diseases?

  2018cites this paper
• Bronchodilators for COPD: At What Stage Should Therapeutic Intervention Be Initiated?

  2017cites this paper
• Cutting edge of COPD therapy: current pharmacological therapy and future direction

  2015cites this paper
• The formulation of a pressurized metered dose inhaler containing theophylline for inhalation.

  2015cites this paper
• Sputum myeloperoxidase in chronic obstructive pulmonary disease

  2014cites this paper
• Theophylline

  2013cites this paper
• Sample sizes for clinical trials using sputum eosinophils as a primary outcome

  2013cites this paper
• Pharmacology and Therapeutics of Bronchodilators

  2012cites this paper
• Low Dose Theophylline Showed an Inhibitory Effect on the Production of IL-6 and IL-8 in Primary Lung Fibroblast from Patients with COPD

  2012cites this paper
• Inhibition of cyclic nucleotide phosphodiesterases by methylxanthines and related compounds.

  2011cites this paper
• Phosphodiesterase inhibitors: factors that influence potency, selectivity, and action.

  2011cites this paper
• New therapeutic options in the management of COPD – focus on roflumilast

  2011cites this paper
• Efficacy of tiotropium in COPD patients from Asia: A subgroup analysis from the UPLIFT trial

  2011cites this paper
• Low dose oral theophylline effects on HS-CRP in stable COPD patients

  2011cites this paper
• Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD

  2010cites this paper
• Roflumilast Roflumilast N-oxide Pyridyl N-oxidationCYP 3 A 4 CYP 1 A 2 Urinary excretion

  2010cites this paper
• Treatment effects of low-dose theophylline combined with an inhaled corticosteroid in COPD.

  2010cites this paper
• Theophylline

  2010cites this paper
• Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of COPD

  2009cites this paper
• [Pharmacological treatment of stable chronic obstructive pulmonary disease].

  2009cites this paper
• Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of chronic obstructive pulmonary disease

  2009cites this paper
• New potential targets to modulate neutrophil function in inflammation.

  2009cites this paper
• Nanomedicine for respiratory diseases.

  2009cites this paper
• The COPDX Plan : Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2009

  2009cites this paper
• Chapter 50 – Theophylline

  2009cites this paper
• Effect of add-on therapy of tiotropium in COPD treated with theophylline

  2008cites this paper
• Anti-inflammatory effects and clinical efficacy of theophylline and tulobuterol in mild-to-moderate chronic obstructive pulmonary disease.

  2008cites this paper
• Equine recurrent airway obstruction and insect bite hypersensitivity: understanding the diseases and uncovering possible new therapeutic approaches.

  2008cites this paper
• Phosphodiesterase 4 inhibitors in chronic obstructive pulmonary disease: a new approach to oral treatment.

  2008cites this paper
• Simultaneous determination of multi drug components Theophylline, Etofylline, Guaiphenesine and Ambroxol Hydrochloride by validated RP-HPLC method in liquid dosage form.

  2008cites this paper
• Long-term treatment with theophylline reduces neutrophils, interleukin-8 and tumor necrosis factor-α in the sputum of patients with chronic obstructive pulmonary disease

  2007cites this paper
• Treating systemic effects of COPD.

  2007cites this paper
• New molecular targets for the treatment of neutrophilic diseases.

  2007cites this paper
• Targeting systemic inflammation: novel therapies for the treatment of chronic obstructive pulmonary disease

  2007cites this paper
• Long-term treatment with theophylline reduces neutrophils, interleukin-8 and tumor necrosis factor-alpha in the sputum of patients with chronic obstructive pulmonary disease.

  2007cites this paper
• Pretreatment with aminophylline reduces release of Troponin I and neutrophil activation in the myocardium of patients undergoing cardioplegic arrest.

  2007cites this paper
• A Xanthine-Based Epithelium-Dependent Airway Relaxant KMUP-3 (7-[2-[4-(4-Nitrobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine) Increases Respiratory Performance and Protects against Tumor Necrosis Factor-α-Induced Tracheal Contraction, Involving Nitric Oxide Release and Expression of cGMP and Protei

  2006cites this paper
• Use of theophylline in chronic obstructive pulmonary disease: examining the evidence

  2006cites this paper
• Anti-fibrotic effects of theophylline on lung fibroblasts.

  2006cites this paper
• Immunomodulatory effects of caffeine: friend or foe?

  2006cites this paper
• COPD—pharmakologische Basisbehandlung und Zukunft der antiinflammatorischen Therapie

  2006cites this paper
• Theophylline for COPD

  2006cites this paper
• Positive benefits of theophylline in a randomized, double‐blind, parallel‐group, placebo‐controlled study of low‐dose, slow‐release theophylline in the treatment of COPD for 1 year

  2006cites this paper
• Histone deacetylase pathway: an evolving therapeutic target in chronic obstructive pulmonary disease

  2006cites this paper
• Thiolated Chitosan Nanoparticles Enhanced Anti-Inflammatory Effects of Intranasally Delivered Theophylline

  2006cites this paper
• [Pharmacological treatment of COPD and future of anti-inflammatory therapy].

  2006cites this paper
• Thiolated chitosan nanoparticles enhance anti-inflammatory effects of intranasally delivered theophylline

  2006cites this paper
• Roflumilast for the treatment of chronic obstructive pulmonary disease.

  2006cites this paper
• Theophylline for Copd Current Use of Theophylline in Copd

  2006cites this paper
• Effects of Different Combined Bronchodilator Therapies on Airway Inflammation in COPD

  2005cites this paper
• COPD: current therapeutic interventions and future approaches

  2005cites this paper
• A xanthine-based epithelium-dependent airway relaxant KMUP-3 increases respiratory performance and protects against TNF-α-induced tracheal contraction, involving NO release and expression of cGMP and PKG

  2005cites this paper
• The COPDX Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2003

  2003cites this paper